NMRA

Neumora Therapeutics, Inc.

Neumora Therapeutics, Inc. (NMRA) has 4 SEC Form 4 filings (4 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Feb 19, 2026.

  • Industry:Biotechnology
  • CEO:Paul L. Berns
  • Employees:96
  • HQ:Watertown, MA, US
  • IPO:2023-09-15

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$83K

reported sales (SEC code S)

Unique Insiders

4

in the rolling window

Source
BERNS PAUL LFirst filing
Sale$34KFeb 19SEC ↗
Pinto JoshuaFirst filing
Sale$21KFeb 19SEC ↗
Sale$5KFeb 19SEC ↗
Sale$22KFeb 19SEC ↗

Related companies

Neumora Therapeutics, Inc. is in the Healthcare sector.